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Abstract
Background: Staphylococcus aureus is the most common agent of septic arthritis that is a severe, rapidly
progressive and destructive joint disease. Superantigens produced by S. aureus are considered the major
arthritogenic factors. In this study, we compared the arthritogenic potential of five superantigen-producing
staphylococcal strains.
Methods: Male C57BL/6 mice were intravenously infected with ATCC 19095 SEC+, N315 ST5 TSST-1+, S-70 TSST-1+,
ATCC 51650 TSST-1+ and ATCC 13565 SEA+ strains. Clinical parameters as body weight, arthritis incidence and
clinical score were daily evaluated. Joint histopathological analysis and spleen cytokine production were evaluated
at the 14th day after infection.
Results: Weight loss was observed in all infected mice. ATCC 19095 SEC+, N315 ST5 TSST-1+ and S-70 TSST-1+ were
arthritogenic, being the highest scores observed in ATCC 19095 SEC+ infected mice. Intermediate and lower clinical
scores were observed in N315 ST5 TSST-1+ and S-70 TSST-1+ infected mice, respectively. The ATCC 13565 SEA+
strain caused death of 85% of the animals after 48 h. Arthritis triggered by the ATCC 19095 SEC+ strain was
characterized by accentuated synovial hyperplasia, inflammation, pannus formation, cartilage destruction and bone
erosion. Similar joint alterations were found in N315 ST5 TSST-1+ infected mice, however they were strikingly more
discrete. Only minor synovial proliferation and inflammation were triggered by the S-70 TSST-1+ strain. The lowest
levels of TNF-α, IL-6 and IL-17 production in response to S. aureus stimulation were found in cultures from mice
infected with the less arthritogenic strains (S-70 TSST-1+ and ATCC 51650 TSST-1+). The highest production of IL-17
was detected in mice infected with the most arthritogenic strains (ATCC 19095 SEC+ and N315 ST5 TSST-1+).
Conclusions: Together these results demonstrated that S. aureus strains, isolated from biological samples, were able
to induce a typical septic arthritis in mice. These results also suggest that the variable arthritogenicity of these
strains was, at least in part, related to their differential ability to induce IL-17 production.
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Background
Staphylococcus aureus is a major cause of bacteremia
which frequently leads to infective endocarditis, meta-
static abscess formation, toxic shock syndrome, gastro-
enteritis, pneumonia, osteomyelitis and septic arthritis
(SA) [1]. The development of these secondary infections
is due to bacterial dissemination from the blood to sur-
rounding tissues and is associated with significantly in-
creased morbidity and mortality [1]. Even though all
these secondary infections are severe, SA deserves spe-
cial attention because it is a rapidly progressive and
highly erosive disease of the joints that needs an imme-
diate therapeutical intervention [2,3]. The most import-
ant risk factor for SA is pre-existing joint disease,
especially rheumatoid arthritis (RA) and prosthetic joint
surgery [2]. The mortality rate in patients with SA is ele-
vated; around 5-20% of adults with this disease may die
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as a consequence of their systemic infection [3]. How-
ever, in RA patients that have S. aureus infections in
more than one joint, the mortality risk increases to 50%
due to the combination of delayed diagnosis, therapeutic
immunosuppression, older age and also the polyarticular
involvement [2,3].
One of the hallmarks of SA is the massive inflamma-
tion that anticipates bone destruction. The infection by
S. aureus is accompanied by a rapid recruitment of poly-
morphonuclear granulocytes and activated macrophages
that are then followed by T cells [4]. Although mono-
cytes and macrophages are important to clear bacteria,
they also play a pivotal role in the destructive inflamma-
tion within the joint [5]. The involvement of pro-
inflammatory cytokines in the pathogenesis of S. aureus
infection has been reported. This bacteria can induce cy-
tokines such as TNF-α, IFN-γ, IL-1, IL-2, and IL-6 [6,7].
Cytokines released from macrophages as TNF-α, IL-1β
and IL-6 have been classically pointed as the major
players of the severe inflammation that precedes cartil-
age and bone destruction in SA [2]. The role of IL-17 in
SA is not well established. However, a possible deleteri-
ous role is highly supported by many reports in the areas
of rheumatoid arthritis and osteoarthritis [8]. IL-17A
appears to play a key role in host defense against local
S. aureus infections by inducing the production of
neutrophil-mobilizing chemokines, colony-stimulating
factors, and cytokines [9].
S. aureus strains can produce a number of different
components that may contribute to virulence and
arthritogenicity, including surface-associated adhesins,
capsular polysaccharides, clumping factor A, exoen-
zymes, and exotoxins [10-12]. Some of the toxins pro-
duced by S. aureus are called superantigens (SAgs)
because they are endowed with the ability to activate
various T cell clones, independently of their specificity.
These SAgs mediate T cell activation in a very distinctive
way from conventional antigens. These molecules are
able to simultaneously bind to class II molecules, on
antigen presenting cells, and to a large T cell population
comprising all clones that share certain variable regions
in the TCR Vβ chain [13]. They cause fever, hypotension
and other acute toxic-shock-like symptoms by inducing
the release of pro-inflammatory cytokines, such as IFN-γ,
TNF-α, IL-1 and IL-12 [14,15].
Several studies indicate that experimental staphylococ-
cal arthritis in mice is the best model to study SA be-
cause of the striking resemblances between the murine
and human immune systems [16,17]. The characteristics
of the murine model closely mirror changes seen in hu-
man SA, especially with regard to the high frequency
and severity of periarticular bone erosivity [4]. LS-1
strain is able to produce TSST-1 and is the most
employed S. aureus strain to trigger experimental SA
[5,16,17]. The main objective of this work was to compare
the arthritogenic potential of various SAg-producing
staphylococci. Disease incidence, clinical scores, histo-
pathological alterations and cytokine production were the
criteria used to characterize arthritis severity.
Methods
Experimental design
Mice were infected with different S. aureus strains and
were daily evaluated by a clinical follow-up that included
weight determination, disease incidence and individual
clinical scores. Fourteen days after infection they were
euthanized and submitted to histopathological and im-
munological analysis. Cellular immunity was checked
considering cytokine production by spleen cells stimu-
lated with S. aureus and Concanavalin A (ConA). Non-
infected animals were included as a control group. Each
group contained 5-9 animals.
Animals
Male C57BL/6 mice (8-10 weeks old) were purchased
from PUSP-RP (USP, São Paulo, SP, Brazil). The animals
were fed with sterilized food and water ad libitum and
were manipulated in accordance with the ethical guide-
lines adopted by the Brazilian College of Animal Experi-
mentation. All experimental protocols were approved by
the local ethics committee for animal experimentation
(CEEA), Medical School, Univ. Estadual Paulista (proto-
col number 291).
S. aureus strains and culture conditions
The following SAg producer strains were used: ATCC
19095 SEC+, N315 ST5 TSST-1+, S-70 TSST-1+, ATCC
51650 TSST-1+, and ATCC 13565 SEA+. Information re-
lated to original isolation and investigations done with
these strains is depicted in Table 1. Before each experi-
ment, bacteria were cultured in blood agar plates
(Merck) for 24 h at 37°C in order to confirm their purity
and to determine their morphology and specific color.
Isolated colonies were inoculated in brain heart broth
(BHI, Merck) and incubated in 37°C for 24 h. Bacteria
were collected by centrifugation, washed three times and
resuspended in cold sterile saline, as described by França
et al., (2009) [18]. The bacterial suspensions were pre-
pared according to the McFarland nephelometer n° 0.5.
The exact amount of live bacterial cells was determined
by further enumeration of the number of colony forming
units (CFU) on agar plates.
Arthritis induction
Disease was induced according to the methodology de-
scribed by Bremell et al. (1991), slightly modified [17].
The infection was performed through the retro-orbital
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route instead of the caudal vein as originally described.
Each animal was infected with 0.2 mL of a S. aureus sus-
pension made in physiological saline and control mice
were injected with 0.2 mL of this diluent. The exact
amount of bacteria injected in each group is indicated in
Table 1.
Clinical evaluation
Arthritis was defined as a visible joint erythema and/or
swelling of at least one joint. Mice were individually ana-
lyzed and joints were inspected every day. The number
of arthritic limbs per animal was registered. Arthritis in-
tensity was recorded as described by Abdelnour et al.
(1993) [24]. Briefly, the arthritic index (clinical score)
was carried out by using a system where macroscopic
inspection yielded a score of 0–3 points for each limb
(1 point = mild swelling and/or erythema; 2 points =
moderate swelling and erythema; 3 points = marked
swelling and erythema). The clinical score of each group
was determined by dividing the total score (sum of the
scores of all animals of each group) by the total number
of animals in each group.
Histopathological examination
Joint histopathological examination was done 14 days
after infection. After fixation by 10% formaldehyde, the
joints were decalcified for 8 weeks in a solution with
18% of ethylenediamine tetraacetic acid. After confirm-
ation that joints were decalcified by a radiographical
procedure, they were washed, dehydrated, and embed-
ded in paraffin. Serial sections with 5 μm thickness were
cut and stained with haematoxylin and eosin. The sec-
tions were semi-quantitatively evaluated in relation to
the presence of inflammatory infiltrates, synovial mem-
brane hyperplasia, pannus formation, cartilage destruc-
tion and bone erosion.
Cytokine quantification
Control and infected animals were euthanized 14 days
after infection. Spleen cells were collected and adjusted
to 5x106cells/mL. Cells were cultured in complete RPMI
medium (RPMI supplemented with 5% of fetal calf
serum, 20 mM glutamine and 40 IU/mL of gentamicin).
Cultures were stimulated with a standardized prepar-
ation of S. aureus (Pansorbin from Calbiochemical) or
ConA (Sigma-Aldrich). Pansorbin is a suspension of
heat-killed and formalin-hardened S. aureus Cowan I
cells and was used at a final dilution of 1:2500 (v:v);
ConA was used at a final concentration of 10 μg/mL in
the cell culture. Cytokine levels were evaluated 48 h later
by enzyme-linked immunosorbent assay (ELISA) in cul-
ture supernatants using IFN-γ BD OptEIA Sets (Becton
Dickinson) and IL-6, IL-17 and TNF-α Duosets (R&D
Systems, Minneapolis, MN, USA). The assays were
performed according to the manufacturer’s instruction.
Statistical analysis
Data were expressed as mean ± SE. Comparisons be-
tween infected groups were made by Student’s test or
one way ANOVA with Tukey test for parameters with
normal distribution. Significance level was p < 0.05. Stat-
istical analysis was accomplished with SigmaStat for
Windows v 3.5 (Systat Software Inc).
Results
Weight loss
Body weight was daily checked. The percentage of
weight variation after 3, 7 and 14 days of infection is il-
lustrated in Figure 1. As can be observed, in spite of
some variation, infection with all strains usually deter-
mined a significant weight loss.
Arthritis incidence
The kinetics of arthritis development was very similar in
the groups infected with ATCC 19095 SEC+ and N315
ST5 TSST-1+. Both groups already presented clinical dis-
ease signs (edema and/or erythema) 24 hours after infec-
tion. They also reached around 80% of disease incidence.
The S-70 TSST-1+ infected group presented delayed
clinical manifestation that occurred only at the 5th day
of infection. A 100% disease incidence was observed in
this group at the 10th day of infection. The ATCC 51650
TSST-1+ strain did not trigger any sign of arthritis dur-
ing the planned experimental period. These results are
shown in Figure 2a. The ATCC 13565 SEA+ strain
caused death of 85% of the animals in 48 h (not shown).
Clinical scores
Clinical scores are shown in Figure 2b. The highest clin-
ical scores were observed in the group infected with the
Table 1 S. aureus strains: origin and infection doses
Strains Source Inoculum Reference
ATCC 19095 SEC+ Leg abscess of a patient (Albert Merritt Billings Hospital, University of Chicago, 1933) 2.2x107 [19]
N315 ST5 TSST-1+ Pharyngeal smear of a japanese patient, 1982 9.4x107 [20]
S-70 TSST-1+ Secretion of a newborn patient (Botucatu, Brazil, 2007) 7.9x108 [21]
ATCC 51650 TSST-1+ Wound of a patient with nonmenstrual toxic shock syndrome, Vancouver, British Columbia, Canada 7.8x1011 [22]
ATCC 13565 SEA+ Food poisoning (Vancouver, Wash, 1940) 1.3x107 [23]
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Figure 1 Weight variation in C57BL/6 mice infected with S. aureus strains. Animals were infected with ATCC 19095 SEC+, N315 ST5 TSST-1+,
S-70 TSST-1+ or ATCC 51650 TSST-1+. Weight variation at 3, 7 and 14 days after infection is illustrated. Data is presented by mean ± SE of 5-9 mice.
*represents the difference between initial weight and the weight in each time interval. p < 0.05.
Figure 2 Arthritis development in C57BL/6 mice infected with S. aureus strains. Animals were infected with ATCC 19095 SEC+, N315 ST5
TSST-1+, S-70 TSST-1+ or ATCC 51650 TSST-1+. (a) Arthritis incidence and (b) clinical score were daily evaluated. Data is presented by mean ± SE
of 5-9 mice. * represents the difference with the group infected with the non arthritogenic ATCC 51560 TSST-1+ strain. p < 0.05.
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ATCC 19095 SEC+ strain. In spite of some variation,
these high scores were maintained until the end of the
experimental period. Even though hind paws and fore-
paws were affected, the hind paws presented higher
scores (not shown). Lower clinical scores were observed
in N315 ST5 TSST-1+ and S-70 TSST-1+ infected mice.
The ATCC 51650 TSST-1+ did not provoke any clinical
sign of arthritis. The ATCC 13565 SEA+ strain was lethal
to 85% of the animals, but the remaining 15% did not
develop any clinical sign of arthritis.
Histopathological analysis
The normal histological pattern of mice joints is shown
in Figures 3a and 3a’. A very thin synovial layer, a
marked joint cavity, an intact cartilage and a preserved
bone structure can be observed. After 14 days of infec-
tion the histological aspect of swollen joints from fore-
paws was very distinct in the three experimentally
infected groups. Mice infected with the ATCC 19095
SEC+ strain presented a severe arthritis characterized by
a marked proliferation of synovial tissue and a huge in-
flammatory process. The inflammatory infiltrate was
mainly localized inside the synovial cavity but it also
penetrated into the cartilage and the bone. A striking
pannus formation occupied almost the entire joint cav-
ity. Cartilage and bone erosion were also observed in
many areas (Figures 3b and 3b’). Synovial hyperplasia,
inflammation, pannus formation and cartilage and bone
erosion were also detected in mice infected with
the N315 ST5 TSST-1+ strain but in lesser extension
(Figures 3c and 3c’). As shown in Figures 3d and 3d’,
only minor degrees of synovial proliferation and inflam-
mation were detected in the joints of mice infected with
the S-70 TSST-1+ strain. Arthritis in the hind paws of
ATCC 19095 SEC+ infected animals was even more se-
vere than in the forepaws. In this case, the synovial space
was entirely occupied by inflammatory infiltrates and
bone tissue was severely eroded (Figures 4b and 4b’).
Various cell types as polymorphonuclear cells, mono-
nuclear cells and fibroblast-like cells were observed.
Granuloma-like structures were also visualized in these
joints. Histopathological changes were not detected in
the hind paws of animals infected with N315 ST5 TSST-
1+ or S-70 TSST-1+ S. aureus strains as can be observed
in Figures 4c and 4d.
Cytokine production
The cellular immune response was evaluated by the pro-
duction of cytokines by spleen cells stimulated with fixed
S. aureus Cowan strain I or ConA. High levels of IFN-γ
were produced by cells stimulated with S. aureus. Even
though these levels were generally similar to the ones
produced by cells from control (non-infected) mice, the
ATCC 19095 SEC+ and S-70 TSST-1+ infected groups
produced significantly higher amounts than the ATCC
51650 TSST-1+ group (Figure 5a). Stimulation with
ConA triggered elevated IFN-γ production by all experi-
mental groups including, as expected, the control group
(Figure 5a). All groups produced TNF-α when the cells
were stimulated with S. aureus, being the levels found in
the control, ATCC 19095 SEC+ and N315 ST5 TSST-1+
similarly elevated. The levels of this cytokine were, how-
ever, significantly lower in the groups S-70 TSST-1+ and
ATCC 51650 TSST-1+ (Figure 5c). Production of IL-6
induced by S. aureus was significantly lower in the group
infected with S. aureus S-70 TSST-1+ (Figure 5b). A very
similar profile was observed when the cultures were
stimulated with ConA, i.e., significantly lower levels of
IL-6 were produced by mice infected with S-70 TSST-1+
and ATCC 51650 TSST-1+ strains in comparison to
N315 ST5 TSST-1+ (Figure 5b). The profile of IL-17
production was similar in the cultures stimulated with
S. aureus and ConA, being its levels higher in cultures
from N315 ST5 TSST-1+ and ATCC 19095 SEC+ groups
as can be observed in Figure 5d. The most striking dif-
ferences were, however, observed in the cultures stimu-
lated with S. aureus. In this case, IL-17 levels were
significantly higher in the groups N315 ST5 TSST-1+
and ATCC 19095 SEC+ in comparison to all other
groups (Figure 5d).
Discussion
Septic arthritis is an infectious disease that affects the
joints. Due to its fast evolution, even with prompt therapy,
it can cause irreversible joint damage and even death [2].
S. aureus is the most common causative agent of this dis-
ease and it has been believed that SAg-production plays a
pivotal role in arthritogenicity [2,15]. The main goal of this
work was to compare the arthritogenic potential of SAg-
producing S. aureus strains considering disease incidence,
clinical score and histopathological alterations. Cytokine
production was also evaluated to get some insight into
possible differences among the various strains. An initial
screening process was performed to evaluate susceptibility
of C57BL/6 and BALB/c mice to develop septic arthritis
after S. aureus infection. Gender effect was also checked.
This preliminary evaluation, that was done only with the
ATCC 19095 SEC+ strain, indicated that male and female,
from both mice strains, lost a significant percentage of
weight in the first days of infection. We believe that all an-
imals were similarly infected because weight loss is ac-
cepted as a parameter to indicate effective infection [25].
However, only C57BL/6 male mice developed arthritis.
This resistance of BALB/c mice to develop experimental
arthritis was already described by Bremmel et al. (1991)
[17]. Our results were, however, distinct from the more re-
cently published data of Henningsson et al. (2010) [26].
These authors described a high incidence of arthritis in
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Figure 3 Histopathological analysis in forepaw joints from C57L/6 mice infected with S. aureus strains. (a, a’) non-infected control. (b, b’)
infected with ATCC 19095 SEC+. (c, c’) infected with N315 ST5 TSST-1+. (d, d’) infected with the S-70 TSST-1+. (a), (b), (c), (d) and (a’), (b’), (c’), (d’)
represent histopathological micrographics with 4x and 10x magnification, respectively. JC, joint cavity; C, cartilage; B, bone; SH, synovial
hyperplasia; BE, bone erosion; CE cartilage erosion; P, pannus formation and IC, inflammatory cells. Panel is representative of 5-9 animals/group.
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Figure 4 Histopathological analysis in hind paw joints from C57L/6 mice infected with S. aureus strains. (a, a’) non-infected control. (b, b’)
infected with ATCC 19095 SEC+. (c, c’) infected with N315 ST5 TSST-1+. (d, d’) infected with the S-70 TSST-1+. (a), (b), (c), (d) and (a’), (b’), (c ’), (d’)
represent histopathological micrographics with 4x and 10x magnification, respectively. JC, joint cavity; C, cartilage; B, bone; BE, bone erosion; CE
cartilage erosion; P, pannus formation and IC, inflammatory cells. Panel is representative of 5-9 animals/group.
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both male and female C57BL/6 mice infected with the LS-1
TSST-1+ S. aureus strain. This variable susceptibility could
be related, at least partially, to S. aureus strain particular-
ities. C57BL/6 male mice were, therefore, chosen to com-
pare the arthritogenic potential of the different S. aureus
strains. These animals were then infected by the retro-
orbital plexus and body weight and clinical scores were
daily checked until the 14th day when animals were eutha-
nized for histopathological and immunological evaluations.
The fact that inoculation of all 5 strains triggered significant
weight loss, suggests successful experimental infections as
has been proposed by other authors [25].
Arthritis incidence and clinical scores varied among
S. aureus strains. ATCC 19095 SEC+ and N315 ST5
TSST-1+ were the most arthritogenic ones. They trig-
gered earlier symptoms and the highest levels of inci-
dence. The ATCC 19095 SEC+ strain was associated
with the highest clinical scores. The S-70 TSST-1+
infected group presented a delayed clinical manifestation
and lower clinical scores whereas the ATCC 51650
TSST-1+ strain did not cause any sign of arthritis during
14 days. The ATCC 13565 SEA+ provoked death of 85%
of the animals after 48 h (not shown). If these differen-
tial outcomes in mice can be translated to human SA is
a subject that needs further investigation. Many bacterial
components are thought to contribute to arthritogenicity
[10-12]. The delayed appearance of arthritis in S-70
TSST-1+ infected mice could mean, for example, that
this strain is endowed with a smaller number of
arthritogenic factors than the other ones. In this sce-
nario, we could think that this strain is being better con-
trolled by the innate immunity. Alternatively, some
strains, as seems to be the case of S-70 TSST-1+, could
be less inflammatory. The level of pro-inflammatory cy-
tokines showed by our results indicates that this less
arthritogenic strain induced lower levels of TNF-α, IL-6
and IL-17 than the two more arthritogenic ones.
No direct relationship was found between arthritogenicity
and bacterial inoculum. By comparing bacterial inoculum
with the degree of arthritis severity, we can conclude that
Figure 5 Production of cytokines by spleen cell cultures stimulated with S. aureus and ConA. C57BL/6 mice were infected with ATCC
19095 SEC+, ATCC N315 ST5 TSST-1+, ATCC S-70 TSST-1+, and ATCC 51650 TSST-1+. IFN-γ (a), IL-6 (b), TNF-α (c) and IL-17 (d) were quantified in
culture supernatants by ELISA after 48 h of incubation. Data is presented by mean ± SE of 5-9 mice. *represents statistical difference between the
two indicated groups. p < 0.05.
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the differential arthritis severity was not associated with dis-
tinct bacterial concentrations. We cannot rule out, however,
the possibility that these strains present distinct potential to
colonize the joints. Unexpectedly, even though the bacterial
suspensions from the 5 strains were prepared by the same
methodology, they really contained distinct number of vi-
able bacteria. This subject was not further evaluated but it
suggests that these preparations could have distinct propor-
tions of dead and alive bacteria. Concerning this differential
arthritogenicity among S. aureus strains we would like to
highlight two aspects. This is the first demonstration that
these strains, that were originally isolated from biological
samples, can cause septic arthritis in mice. In addition,
these results indicate that superantigenicity was not enough
to elicit arthritis. The ATCC 51650 TSST-1+ strain, for ex-
ample, was not able to induce septic arthritis, even though
it was used in the adequate range of bacterial concentration
[16]. This finding is in accordance with the postulate that
induction of arthritis by S. aureus infection is likely elicited
by the concerted action of multiple events as activation of
T lymphocytes by SAgs, exposure to peptidoglycans/capsu-
lar polysaccharides, presence of surface-associated adhesins,
clumping factor A and also free bacterial DNA [2,10-12].
Even though not clearly demonstrated in the literature, the
ability of S. aureus to form biofilms with joint components
is being suggested as a possible arthritogenic element
[27,28]. In this sense, it would be very enlightening to com-
pare the ability of these S. aureus strains to form biofilms.
The histopathological analysis of the joints revealed
the presence of synovial proliferation, pannus formation
and inflammatory infiltrates in the joint cavity. These
findings are similar to the most consensual features of
SA caused by S. aureus [29]. Cartilage and bone erosion
were also present, mainly in joints from animals infected
with the ATCC 19095 SEC+ strain. This evolution from
the inflammatory process to cartilage and bone erosion
is very relevant because it mimicries the human situation
during SA by S. aureus. In this case, 25-50% of the pa-
tients progress to bone destruction and irreversible loss
of joint function [30-32].
TNF-α, IL-6 and IL-17 are being described as some of
the most relevant mediators in SA immunopathogenesis
[26,33]. To investigate the possible contribution of cyto-
kines to these histopathological alterations, the production
of TNF-α, IFN-γ, IL-6 and IL-17 was simultaneously
quantified in spleen cultures stimulated with S. aureus or
ConA. Even though all of them can be released during the
initial innate immunity, IFN-γ and IL-17 can also be pro-
duced during specific immunity by effector Th1 and Th17
cells, respectively. Interestingly, the lowest levels of TNF-α,
IL-6 and IL-17 were found in cultures from mice that
presented the lowest clinical scores. In addition, differently
from IFN-γ, TNF-α and IL-6, IL-17 was not produced by
spleen cells from normal mice. The highest production of
IL-17 was observed in infections caused by the more
arthritogenic strains, i.e., ATCC 19095 SEC+ and N315
ST5 TSST-1+. The role of IL-17 as a mediator of joint de-
struction is being elucidated in experimental RA. The
intra-articular injection of IL-17 into the knee results in
joint inflammation and local damage [32]. This effect has
been attributed, at least partially, to IL-17 induction of
matrix metalloproteinases and also to its ability to pro-
mote osteoclastogenesis [34]. IL-17 also induces produc-
tion of IL-6 and IL-8 by RA synovial fibroblasts via NF-kB
and PI3-kinase/Akt-dependent pathways [35]. Further-
more, this cytokine induces production of chemokines
and other pro-inflammatory cytokines such as TNF-α, IL-
1β, CXCL1 and CXCL5 [36,37]. These cytokines affect
bone remodeling by stimulating proliferation and differen-
tiation of osteoclast progenitors into mature osteoclasts
[38,39]. Contrasting with this well-established role of IL-
17 in RA, the role of IL-17 in S. aureus-induced arthritis
is not well understood. To our knowledge, this higher
production of IL-17 in mice infected with the most
arthritogenic strains is being described for the first time.
Although this cytokine has been associated with protec-
tion in animals immunized with clumping factor A and
also with local host defense during S. aureus-induced arth-
ritis, its arthritogenic contribution in SA is still not
disclosed. In this sense, these results support the possibil-
ity that higher IL-17 inducer S. aureus strains are endowed
with stronger arthritogenic abilities [26,40].
Conclusions
Altogether, these results demonstrated that S. aureus
strains, isolated from biological samples, were able to in-
duce typical septic arthritis in mice. These results also
suggest that the variable arthritogenicity of these strains
was, at least in part, related to their differential ability to
induce IL-17 production.
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